MARCELINA GOMEZ ALMAZAN: Open Payments
NPI 1407454283 · LOVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 36 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $498 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| Lilly USA, LLC | 7 | $137 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Insulet Corporation | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 3 | $19 |
| Phadia US Inc. | 1 | $17 |
Products named: MOUNJARO, AIRSUPRA, GARDASIL 9, Ozempic, Rybelsus, Cologuard Collection Kit, CAPLYTA, Wegovy.
Industry payments across OH — which companies pay providers there.
